Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. According to the Association of the British Pharmaceutical industry (ABPI), the “radical plans” are “unworkable”.

Government 130

Government Pharma Companies Science Pharmaceuticals 130

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. I am a pharmacist by training and continued with a PhD in Clinical Pharmacology.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. This includes products with complex active ingredients or complex formulations, drug-device combination products, or complex routes of delivery.

Production 130

Production Pharma Companies Clinical Trials FDA 130

H1 Blog

JULY 30, 2024

This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements. “Now,

FDA 59

FDA Compliance Clinical Trials Pharma Companies 59

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

Drug Discovery World

NOVEMBER 16, 2022

In April 2021, life sciences solutions provider Molecular Devices launched its Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process. . 2D biology has been used by pharmaceutical researchers for decades. 2D vs 3D . 2D vs 3D .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

The Pharma Data

SEPTEMBER 22, 2020

Swiss pharma company to acquire biotech for $449m (€380m). Swiss pharma company Roche is set to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m). Activated NLRP3 is involved in the production of pro-inflammatory cytokines IL-1? Source link.

Pharma Companies 52

Pharma Companies Small Molecule Pharmaceutical Companies Disease 52

Predictive Oncology

FEBRUARY 7, 2023

NEW YORK – Predictive Oncology wants to ink more partnerships with biopharmaceutical companies and demonstrate the ability of its commercially available PEDAL platform to provide early insights that sponsors can use to prioritize drugs for development and identify biomarker-informed indications.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Trials Trials Pharmaceuticals 52

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. AI and big data are now commonly involved with drug discovery and development.

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Drug Target Review

OCTOBER 1, 2024

Following clinical practice, I transitioned to the world of pharmaceutical companies which also had its challenges as I had to learn everything from scratch and use my experience and knowledge differently. Being a doctor means giving courage and hope day in, day out to those experiencing illness.

Doctors 64

Doctors Therapies Science Pharma Companies 64

Drug Discovery World

SEPTEMBER 29, 2022

Challenges in outsourcing drug discovery. In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring. . The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

Eye on FDA

JANUARY 9, 2022

Once again it was a quiet year with respect to the FDA’s Office of Prescription Drug Programs (OPDP). In the latest published guidance agenda from the Center for Drug Evaluation and Research, the advertising and promotion category had no slated guidance efforts listed. Why This is a Fail.

FDA 64

FDA Pharma Companies Pharmaceutical Companies Production 64

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. It is approved in Argentina as the world’s first therapy for severe Chronic Fatigue Syndrome and is the only late-stage drug in the U.S. Ampligen is AIM’s TLR3 agonist immune-system modulator. development pipeline for ME/CFS.

Clinical Trials 52

Clinical Trials Trials Virus International 52

Advarra

JULY 19, 2022

If the sponsor wants their drug approved, they need to complete all clinical studies and submit an application. Q: Please discuss the transfer of investigational new drug (IND) sponsorship from one sponsor to another and that process. The sponsor is the pharmaceutical company conducting the trial.

Packaging 52

Packaging FDA Regulations Trials 52

DrugBank

JUNE 27, 2024

Drug repurposing is an approach that, while not new, has become popular in the last decade.   One of the most exciting prospects of drug repurposing is its potential to tackle "undruggable" targets—proteins or molecules that traditional drugs can't easily bind to.

Drugs 71

Drugs Pharma Companies Computational Chemistry Clinical Trials 71

Drug Discovery World

NOVEMBER 15, 2022

Anita Ramanathan outlines four synthetic biology approaches that are improving and accelerating drug discovery. . It has made its way into almost every aspect of drug discovery, whether it’s exploring basic biology, modelling diseases, identifying and validating targets, or performing drug screens. .

DNA 246

DNA Engineering Drugs Vaccine 246

Drug Discovery World

JANUARY 26, 2023

However, coming off the back of high levels of return on investment (ROI) seen throughout Covid-19 and therefore 2021, was always going to be difficult for the pharma industry. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Drug Discovery World

MAY 7, 2024

And as a key figure, she understands that with drug discovery being such a contested field, both in terms of attracting funding and drawing the attention of government, making AMR a topic on everyone’s agendas is challenging. The post Why more work is needed to fight antimicrobial resistance appeared first on Drug Discovery World (DDW).

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

Drug Discovery World

AUGUST 10, 2023

Remco Munnik (RM): Up to now, regulatory has always been the spider in the web within a pharmaceutical company – collecting all of the relevant information for submission of the registration: Clinical, CMC, administrative data, etc – then compiling a valid eCTD by the submission deadline.

Pharmaceutical Companies 245

Pharmaceutical Companies Production Science Pharma Companies 245

The Connected Lab

APRIL 8, 2020

Prescription drugs have the ability to transform a patient’s life and provides them the opportunity to rid a devastating illness, making the development and approval of these medications urgent and necessary. However, over the last 10 years the path leading to drug approval has become more complicated and expensive.

Pharma Companies 52

Pharma Companies Laboratories FDA Approval Drugs 52

Drug Discovery World

JANUARY 5, 2023

There is a real danger for companies simply reacting to the latest EMA mandates, such as the specifics of how data will look under the EU’s eventual implementation of Identification of Medicinal Products (IDMP), and the perceived ‘watering down’ of data-driven process requirements via the shift to Digital Application Dataset Integration (DADI).

Pharma Companies 130

Pharma Companies International Compliance Production 130

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Drug Target Review

MAY 23, 2023

9 Academic scientists researching natural products often struggle with the pitfalls of drug development. Pharmaceutical companies meanwhile need to reinvest in natural product research. Their combined action is needed to treat complex diseases such as IBD. Dorit also coordinates the EU-funded research project Algae4IBD.

Drugs 75

Drugs Small Molecule Production Pharma Companies 75

Elrig

APRIL 29, 2024

Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Target Review

APRIL 19, 2024

Identifying new drugs is an extremely complex project. The scientific founders have developed a pioneering method for drug discovery that applies to the research and design of new drugs effective against diseases that are incurable to date. We are now in the preclinical stage of developing a proprietary drug pipeline.

Molecular Biology 111

Molecular Biology Pharmaceuticals Research Small Molecule 111

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. Changes in the blood concentration profile of a drug.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Production 52

The Pharma Data

NOVEMBER 11, 2020

There currently are no approved drug treatment options for this condition. We are honored to partner with Taiho, a Japanese pharmaceutical company with a commitment to the respiratory field, for the development and commercialization of LTI-01 in Japan. About Taiho Pharmaceutical Co.,

Licensing 40

Licensing Licensing Treatment Pharma Companies 40

Drug Discovery World

AUGUST 16, 2022

The drug discovery sector is working to address cancer disparities. Anita Ramanathan examines the importance of inclusivity and diversity throughout the drug discovery and development process. . Here, we highlight the efforts being made to achieve cancer health equity at different stages of drug development. .

Research 130

Research Clinical Trials Trials Drug Development 130

Codon

FEBRUARY 13, 2024

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies 118

Therapies Virus DNA Clinical Trials 118

Drug Discovery World

SEPTEMBER 7, 2022

The drug discovery and development process is costly and arduous, offering no certainty of success which often rests on whether a company has chosen the correct drug molecule and target. With its use scattered across the industry, just how are researchers utilising AI to improve drug discovery?

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

Drug Discovery World

AUGUST 23, 2023

There’s even a name for the downsides of such under-supported products, poor integrations, and bad user experience: frustrated ELN users call this the “tax on science” That tax has a real cost in terms of drug discovery. This transition improved intellectual property management for early drug discovery.

Compliance 130

Compliance Laboratories Science Pharma Companies 130

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. Food and Drug Administration granted Breakthrough Therapy designation to France-based Inventiva’s experimental NASH treatment lanifibranor. Inventiva – The U.S.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Pharmaceutical Companies 52

The Pharma Data

DECEMBER 30, 2020

Food and Drug Administration (FDA), noted in December 2020 that he expected the pandemic could “effectively” be ended in 2021 with the launch of the Pfizer-BioNTech and Moderna vaccines. Then, in July, after analyzing completed data and with talks with the FDA, they decided they were going to pursue regulatory approval for the drug.

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug & Device Law

APRIL 7, 2023

A federal judge in DC has reminded us that the government does not operate in secret, at least not always and usually not completely in connection with prescription drug approval. The case is Vanda Pharmaceuticals, Inc. The company lodged a request under the Freedom of Information Act (“FOIA”), which the FDA refused.

FDA 64

FDA Government Pharma Companies Regulations 64